A systematic comparison of the quality and volume of published data available on novel risk factors for stroke versus coronary heart disease

Cerebrovascular Diseases

Volumn 20, Issue 3, 2005, Pages 180-186

  Bhatia, Meena ^a   Rothwell, Peter M ^a,b  

^a Stroke Prevention Research Unit   (United Kingdom)

^b RADCLIFFE INFIRMARY   (United Kingdom)

Author keywords

Acute coronary events; Case control studies; Cohort studies; Risk factors; Stroke

Indexed keywords

APOLIPOPROTEIN; C REACTIVE PROTEIN; FIBRIN;

CHLAMYDOPHILA PNEUMONIAE; FACTORIAL ANALYSIS; HELICOBACTER PYLORI; HUMAN; ISCHEMIC HEART DISEASE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; STROKE; SYSTEMATIC REVIEW;

APOLIPOPROTEINS; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; CEREBROVASCULAR ACCIDENT; CHLAMYDOPHILA PNEUMONIAE; COHORT STUDIES; CORONARY DISEASE; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; FIBRINOGEN; HELICOBACTER PYLORI; HUMANS; PERIODICALS; RISK FACTORS;

EID: 24344448600     PISSN: 10159770     EISSN: None     Source Type: Journal    
DOI: 10.1159/000087202     Document Type: Review

References (89)

1. Bonita R: Epidemiology of stroke. Lancet 1992;339:342-344.
2. MacDonald BK, Cockerell OC, Sander JWAS, Shorvon SD: The incidence and lifetime prevalence of neurological disorders in a prospective community-based study in the UK. Brain 2000;123:665-676.
3. Murray CJL, Lopez AD: Mortality by cause for eight regions of the world: Global burden of disease study. Lancet 1997;349:1269-1276.
4. Prospective Studies Collaboration: Cholesterol, diastolic BP, and stroke: 13,000 strokes in 450,000 people in 45 cohorts. Lancet 1995; 346:1647-1653.
5. Eastern Stroke and Coronary Heart Disease Collaborative Research Group: Blood pressure, cholesterol, and stroke in eastern Asia. Lancet 2001;352:1801-1807.
6. Rodgers A, MacMahon S, Gamble G, Slattery J, Sandercock P, Warlow C for the UK-TIA Group: Blood pressure and risk of stroke in patients with cerebrovascular disease. BMJ 1996;313:147.
7. Neaton JD, Wentworth DN, Cutler J, Stamler J, Kuller L: Risk factors for death from different types of stroke. Multiple Risk Factor Intervention Trial Research Group. Ann Epidemiol 1993;3:493-499.
8. Staessen JA, Gasowski J, Wang JG, Lutgarde T, Hond ED, Boissel J-P, Ekbom T, Gueyffier F, Lisheng L, Kerlikowske K, Pocock S, Fagard RH: Risks of untreated and treated isolated systolic hypertension in the elderly: Meta-analysis of outcome trials. Lancet 2000;355:865-872.
9. PROGRESS Collaborative Group: Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack. Lancet 2001;358:1033-1041.
10. Dippel D, Koudstaal PJ: We need stronger predictors of major vascular events in patients with a recent TIA or non-disabling stroke. Stroke 1997;28:774-776.
11. Sacco RL: Identifying patient populations at high risk of stroke. Neurology 1998;51(suppl 3):S27-S30.
12. Rothwell PM: Incidence, risk factors and prognosis of stroke and transient ischaemic attack: The need for high-quality large-scale epidemiological studies. Cerebrovasc Dis 2003;16(suppl 3):72-10.
13. Schulz UGR, Rothwell PM: Differences in vascular risk factors between aetiological subtypes of ischaemic stroke in population-based incidence studies. Stroke 2003;34:2050-2059.
14. Rothwell PM: The high cost of not funding stroke research: a comparison with heart disease and cancer. Lancet 2001;357:1612-1616.
15. Pendlebury ST, Rothwell PM, Algra A, Ariesen MJ, Bakac G, Czlonkowska A, Dachenhausen A, Krespi Y, Korv J, Krolikowski K, Kulesh S, Michel P, Thomassen L, Bogousslavsky J, Brainin M: Underfunding of stroke research: A Europe-wide problem. Stroke 2004;35:2368-2371.
16. Davies MJ, Thomas AC: Plaque fissuring - the cause of acute myocardial infarction, sudden ischaemic death, and crescendo angina. Br Heart J 1985;53:363-373.
17. Beamer NB, Coull BM, Clark WM, Hazel JS, Silberger JR: Interleukin-6 and interleukin-1 receptor antagonist in acute stroke. Ann Neurol 1995;37:800-804.
18. Beamer NB, Coull BM, Clark WM, Briley DP, Wynn M, Sexton DO, Sexton G: Persistent inflammatory response in stroke survivors. Neurology 1998;50:1722-1728.
19. Blake GJ, Dada N, Fox JC, Manson JE, Ridker PM: A prospective evaluation of lipoprotein-associated phospholipase A2 levels and the risk of future cardiovascular events. J Am Coll Card 2001;38:1302-1306.
20. Bostom AG, Gagnon DR, Cupples A, Wilson PWF, Jenner JL, Ordovas JM, Schaefer EJ, Castelli WP: A prospective investigation of elevated lipoprotein (a) detected by electrophoresis and cardiovascular disease in women. Circulation 1994;90:1688-1695.
21. Bots ML, Elwood PC, Salonen JT, Freire de Cocalves A, Sivenius J, Di Carlo A, Nikitin Y, Benetou V, Tuomilehto J, Koudstaal PJ, Grobbee DE: Levels of fibrinogen and risk of fatal and nonfatal stroke. Eurostroke: A collaborative study among research centres in Europe. J Epidemiol Comm Health 2002;56:114-118.
22. Boutron MC, Giroud M, Gras P, Gambert P, Lallemant C, Milan C, Essayagh E, Dumas R: Plasma lipoproteins in cortical infarction versus transient ischaemic attacks: a case control study. J Neurol 1993;240:133-138.
23. Canova CR, Courtin C, Reinhart WH: C-reactive protein in cerebrovascular events. Atherosclerosis 1999;147:49-53.
24. Chien KL, Sung FC, Hsu HC, Su TC, Lin RS, Lee YT: Apolipoprotein A-I and B and stroke events in a community based cohort in Taiwan. Stroke 2002;33:39-44.
25. Cook PJ, Honeybourne D, Lip GY, Beevers DG, Wise R, Davies P: Chlamydia pneumoniae antibody titres are significantly associated with acute stroke and transient cerebral ischaemia. Stroke 1998;29:404-410.
26. Coull BM, Beamer N, de Garmo P, Sexton G, Nordt F, Knox R, Seaman GVF: Chronic hyperviscosity in subjects with acute stroke, TIA and risk factors for stroke. Stroke 1991;22:162-168.
27. Di Napoli M, Papa F, Bocola V: Prognostic influence of increased CRP and fibrinogen levels is ischaemic stroke. Stroke 2001;32:133-138.
28. Di Napoli M, Papa F: Inflammation, hemostatic markers, and antithrombotic agents in relation to long term risk of new cardiovascular events in first-ever ischaemic stroke patients. Stroke 2002;33:1763-1771.
29. Elkind MSV, Lin IF, Grayston JT, Sacco RL: Chlamydia pneumoniae and the risk of first ischaemic stroke. Stroke 2000;31:1521-1526.
30. Fagerberg B, Gnarpe J, Gnarpe H, Agewall S, Wikstrand J: Chlamydia pneumoniae but not cytomegalovirus antibodies are associated with future risk of stroke and cardiovascular disease: a prospective study in middle-aged to elderly men with treated hypertension. Stroke 1999;30:299-305.
31. Feinberg WM, Pearce LA, Hart RG, Cushman M, Cornell ES, Lip GY, Bovill EG: Markers of thrombin and platelet activity in patients with atrial fibrillation. Stroke 1999;2547-2553.
32. Folsom AR, Rosamond WD, Shahar E, Cooper LS, Aleksic N, Nieto J, Rasmussen ML, Wu KK: Prospective study of markers of hemostatic function with risk of ischaemic stroke. Circulation 1999;100:736-742.
33. Ford C, Giles WH: Serum C-reactive protein and self reported stroke. Findings from the third national health and nutrition examination survey. Art Thromb Vasc Biol 2000;20:1052-1056.
34. Giroud M, Creisson E, Fayolle H, Andre N, Becker F, Martin D, Dumas R: Risk factors for primary cerebral hemorrhage: population based study: the stroke registry of Dijon. Neuroepidemiology 1995;14:20-26.
35. Giubilei F, D'Antona R, Antonini R, Lenzi GL, Ricci G, Fieschi C: Serum lipoprotein pattern variations in dementia and ischaemic stroke. Acta Neurol Scand 1990;81:84-86.
36. Glader CA, Stegmayr B, Boman J, Stenlund H, Weinehall L, Hallmans G, Dahlen GH: Chlamydia pneumoniae antibodies and high lipoprotein (a) levels do not predict ischaemic cerebral infarctions. Stroke 1999;30:2013-2018.
37. Grau AJ, Buggle F, Werle E, Hacke W: The association of leucocyte count, fibrinogen and CRP with vascular risk factors and ischaemic vascular diseases. Thromb Res 1996;3:245-255.
38. Grau AJ, Buggle F, Lichy C, Brandt T, Becher H, Rudi J: Helicobacter pylori infection as an independent risk factor for cerebral ischaemia of atherothrombotic origin. J Neurol Sci 2001;186:1-5.
39. Gunther G, Junker R, Strater R, Schobess R, Kurnik K, Kosch A, Nowak-Gottl U: Symptomatic ischaemic stroke in full term neonates. Role of acquired and genetic prothrombotic risk factors. Stroke 2000;31:2437-2441.
40. Gussekloo J, Schaap MCL, Frolich M, Blauw GJ, Westedorp RGJ: C-Reactive protein is a strong but non-specific risk factor of fatal stroke in elderly persons. Art Thromb Vasc Biol 2000;20:1047-1051.
41. Haider AW, Wilson PW, Larson MG, Evans JC, Michelson EL, Wolf PA, O'Donnell CJ, Levy D: The association of seropositivity to Helicobacter pylori, Chlamydia pneumoniae, and cytomegalovirus with risk of cardiovascular disease: A prospective study. J Am Coll Cardiol 2002;40:1408-1413.
42. Heuschmann PU, Neureiter D, Gesslein M, Craiovan B, Maass M, Faller G, Beck G, Neundoerfer B, Kolominsky-Rabas PL: Association between infection with Helicobacter pylori and Chlamydia pneumoniae and risk of ischaemic stroke subtypes. Stroke 2001;32:2253-2258.
43. Jurgens G, Koltringer P: Lipoprotein (a) in ischaemic cerebrovascular disease: A new approach to the risk assessment of risk for stroke. Neurology 1987;37:513-515.
44. Jurgens G, Taddei-Peters WC, Koltringer P, Petek W, Chen Q, Greilberger J, Macomber PF, Butman BT, Stead AG, Ransom JH: Lipoprotein (a) serum concentration and apolipoprotein (a) phenotype severity and pressure of ischaemic cerebrovascular disease. Stroke 1996;26:1841-1848.
45. Kannel WB, Wolf PA, Castelli WP, D'Agostino RB: Fibrinogen and risk of cardiovascular disease. The Framingham Study. JAMA 1987;258:1183-1186.
46. Kargman DE, Tuck C, Berglund L, Lin IF, Mukherjee RS, Thompson EV, Jones J, BodenAlbala B, Paik MC, Sacco RL: Lipid and lipoprotein levels remain stable in acute ischaemic stroke: The northern Manhattan stroke study. Atherosclerosis 1998;139:391-399
47. Kario K, Matsuo T, Kobayashi H, Asada R, Matsuo M: Silent cerebral infarction is associated with hypercoagulability, endothelial cell damage, and high 1p (a) levels in elderly Japanese. Art Thromb Vasc Biol 1996;16:734-741.
48. Kataoka S, Hirose G, Hori A, Shirakawa T, Saigan T: Activation of thrombosis and fibrinolysis following brain infarction. J Neurol Sci 2000;181:82-88.
49. Kristensen B, Malm J, Nilsson TK, Hultdin J, Carlberg B, Olsson T: Increased fibrinogen levels and acquired hypofibrinolysis in young adults with ischaemic stroke. Stroke 1998;29:2261-2267.
50. Kronenberg F, Kronenberg MF, Kiechl S, Trenkwalder E, Santer P, Oberhollenzer F, Egger G, Utermann G, Willeit J: Role of lipoprotein(a) and apolipoprotein(a) phenotype in atherogenesis: Prospective results from the Bruneck study. Circulation 1999;100:1154-1160.
51. Lowe GD, Lee AJ, Rumley A, Price JF, Fowkes FG: Blood viscosity and risk of cardiovascular events: the Edinburgh Artery Study. Br J Haematol 1997;96:168-173.
52. Madre JG, Garcia JLR, Gonzalez, Montero M, Paniagua EB, Escribano RG, Martinez JD, Cenjor RF: Association between seropositivity to Chlamydia pneumoniae and acute ischaemic stroke. Eur J Neurol 2002;9:303-306.
53. Majka J, Rog T, Konturek PC, Konturek PC, Konturek SJ, Bielanski W, Kowalsky M, Szczudlik A: Influence of chronic Helicobacter pylori infection on ischaemic cerebral stroke risk factors. Med Sci Monit 2002;8:675-684.
54. Markus HS, Mendall MA. Helicobacter pylori infection: A risk factor for ischaemic cerebrovascular disease and carotid atheroma. J Neurol Neurosurg Psych 1998;64:104-107.
55. Markus HS, Kapadia R, Sherwood RA: Relationship between lipoprotein (a) and both stroke and carotid atheroma. Ann Clin Biochem 1997;34:360-365.
56. Misirili H, Somay G, Ozbal N, Erenoglu NY: Relation of lipid and lipoprotein (a) to ischaemic stroke. J Clin Neurosci 2002;9:127-132.
57. Moons KGM, Bots ML, Salonen JT, Elwood PC, Freire de Concalves A, Nikitin Y, Sivenius J, Inzitari D, Benetou V, Tuomilehto, Koudstaal PJ, Grobbee DE: Prediction of stroke in general population in Europe (EURO-STROKE): Is there a role for fibrinogen and electrocardiography? J Epidemiol Community Health 2002;56:i30-i36.
58. Nguyen TT, Ellefson RD, Hodge DO, Bailey KR, Kottke TE, Abu-Lebdeh HS: Predictive value of electrophoretically detected lipoprotein(a) for coronary heart disease and cerebrovascular disease in a community-based cohort of 9936 men and women. Circulation 1997;96:1390-1397.
59. Nowak-Gottl U, Strater R, Heinecke A, Junker R, Koch HG, Schuierer G, von Eckardstein A: Lp (a) and genetic polymorphisms of clotting factor V, prothrombin, and methyenetetrahydrofolate reductase are risk factors of spontaneous ischaemic stroke in childhood. Blood 1999;11:3678-3682.
60. Olah L, Misz M, Kappelmayer J, Ajzner E, Csepany T, Fekete I, Bereczki D, Blasko G, Csiba L: Natural coagulation inhibitor proteins in young patients with cerebral ischaemia. Cerebrovasc Dis 2001;12:291-297.
61. Pedro-Botet J, Senti M, Nogues X, Rubies-Prat J, Roquer J, D'Olhaberriague L, Olive J: Lipoprotein and apoliprotein profile in men with ischaemic stroke. Stroke 1992;23:1556-1562.
62. Peng DQ, Zhao SP, Wang JL: Lipoprotein (a) and apolipoprotein E as independent risk factors for ischaemic stroke. J Cardiovasc Risk 1999;6:1-6.
63. Peynet J, Beaudeux JL, Woimant F, Flourie F, Giraudeaux V, Vicaut E, Launay JM: Apolipoprotein (a) size polymorphism in young adults with ischaemic stroke. Atherosclerosis 1999;142:233-239.
64. Pietroiusti A, Diomedi M, Silvestrini M, Cupini LM, Luzzi I, Gomez-Miguel MJ, Bergamaschi A, Magrini A, Carrabs T, Vellini M, Galante A: Cytotoxin-associated gene A positive Helicobacter pylori strains are associated with atherosclerotic stroke. Circulation 2002;106:580-584.
65. Qizilbash N, Jones L, Warlow C, Mann J: Fibrinogen and lipid concentrations as risk factors for transient ischaemic attacks and minor ischaemic strokes. BMJ 1991;303:605-609.
66. Qureshi A, Giles WH, Croft JB, Guterman LR, Hopkins LN: Apolipoproteins A-1 and B and the likelihood of non-fatal stroke and myocardial infarction data from the Third National Health and Nutrition Examination Survey. Med Sci Monit 2002;8:CR311-316.
67. Resch KL, Ernst E, Matrai A, Paulsen HF: Fibrinogen and viscosity as risk factors for subsequent cardiovascular events in stroke survivors. Ann Intern Med 1992;117:371-375.
68. Ridker PM, Hennekens CH, Buring JE, Rifai N: C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 2000;342:836-843.
69. Ridker PM, Stampfer MJ, Hennekens CH: Plasma concentration of lipoprotein(a) and the risk of future stroke. JAMA 1995;273:1269-1273.
70. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH: Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997;336:973-979.
71. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH: Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease. Circulation 1998;97:425-428.
72. Ridker PM, Hennekens CH, Buring JE, Kundsin R, Shih J: Baseline IgG antibody titers to Chlamydia pneumoniae, Helicobacter pylori, herpes simplex virus, and cytomegalovirus and the risk for cardiovascular disease in women. Ann Intern Med 1999;131:573-577.
73. Santos-Silva A, Rebelo I, Castro E, Belo L, Catarino C, Monteiro I, Almeida MD, Quintanilha A: Erythrocyte damage and leucocyte activation in ischaemic stroke. Clin Chim Acta 2002;320:29-35.
74. Scarabin PY, Aillaud MF, Amouyel P, Evans A, Luc G, Ferrieres J, Arveiler D, Juhan-Vague I: Associations of fibrinogen, factor VII and PAI-1 with baseline findings among 10,500 male participants in a prospective study of myocardial infarction. The prime study. Thromb Haemost 1998;80:749-756.
75. Schreiner PJ, Chambless LE, Brown SA, Watson RL, Toole J, Heiss G: Lipoprotein (a) as a correlate of stroke and transient ischaemic attack prevalence in a biracial: The ARIC Study. Ann Epidemiol 1994;4:351-359.
76. Simons LA, Simons J, Friedlander Y, McCallum J: Cholesterol and other lipids predict coronary heart disease and ischaemic stroke in the elderly, but only in those below 70 years. Atherosclerosis 2001;159:201-208.
77. Smith FB, Lee AJ, Fowkes FG, Price JF, Rumley A, Lowe GD: Hemostatic factors as predictors of ischemic heart disease and stroke in the Edinburgh Artery Study. Arterioscler Thromb Vasc Biol 1997;17:3321-3325.
78. Smith FB, Rumley A, Lee AJ, Leng GC, Fowkes FG, Lowe GD: Haemostatic factors and prediction of ischaemic heart disease and stroke in claudicants. Br J Haematol 1998;100:758-763.
79. Tanne D, Benderly M, Goldbourt U, Boyoko V, Brunner D, Graff E, Reicher-Reiss H, Shotan A, Mandelzweig L, Behar S: A prospective study of plasma fibrinogen levels and the risk of stroke among participants in the benzafibrate infarction prevention study. Am J Med 2001;111:457-463.
80. Tarnacka B, Gromadzka G, Czlonkowska A: Increased circulating immune complexes in acute stroke The triggering role of Chlamydia puneumoniae and cytomegalovirus. Stroke 2002;936-940.
81. Tracy RP, Arnold AM, Ettinger W, Fried L, Meilahn E, Savage P: The relationship of fibrinogen and factors VII and VIII to incident cardiovascular disease and death in the elderly: results from the cardiovascular health study. Arterioscler Thromb Vasc Biol 1999;19:1776-1783.
82. van Exel E, Gussekloo J, de Craen AJM, Bootsma van der Wiel A, Frolich M, Westendorp RGJ: Inflammation and stroke. Stroke 2002;33:1135-1138.
83. van Kooten F, van Krimpen J, Dippel DW, Hoogerbrugge N, Koudstaal PJ: Lipoprotein(a) in patients with acute cerebral ischemia. Stroke 1996;27:1231-1235.
84. von Eckardstein A, Schulte H, Cullen P, Assmann G: Lipoprotein(a) further increases the risk of coronary events in men with high global cardiovascular risk. J Am Coll Cardiol 2001;37:434-439.
85. Whincup PH, Mendall MA, Perry IJ, Strachan DP, Walker M: Prospective relations between Helicobacter pylori infection, coronary heart disease and stroke in middle aged men. Heart 1996;75:568-572.
86. Wilhelmsen L, Svardsudd K, Korsan-Bengtsen K, Larsson B, Welin L, Tibblin G: Fibrinogen as a risk factor for stroke and myocardial infarction. N Engl J Med 1984;311:501-505.
87. Wimmer ML, Sandmann-Strupp R, Saikku P, Haberl RL: Association of chlamydial infection with cerebrovascular disease. Stroke 1996;27:2207-2210.
88. Wityk RJ, Kittner SJ, Jenner JL, Hebel JR, Epstein A, Wozniak, Stolley PD, Stern BJ, Sloan MA, Price TR, McCarter RJ, Macko RF, Johnson CJ, Earley CJ, Buchholz, Schaefer EJ: Lipoprotein (a) and the risk of ischaemic stroke in young women. Atherosclerosis 2000;150:389-396.
89. Zenker G, Koltringer P, Bone G, Niederkorn K, Pfeiffer K, Jurgens G: Lipoprotein(a) as a strong indicator for cerebrovascular disease. Stroke 1986;17:942-945.